PDLIM4 and breast cancer: Feng et al. found that PDLIM4 was highly methylated in tumor tissue by analyzing 38 pairs of patients with primary BC lymphatic metastases [129], and other studies showed that PDLIM4 expression was negatively correlated with tumor size, differentiation status, and SPF (S-phase fraction) value [130].